Wenn Sie das Fenster schließen, wird Ihre Konfiguration nicht gespeichert, es sei denn, Sie haben Ihren Artikel in die Bestellung aufgenommen oder zu Ihren Favoriten hinzugefügt.
Klicken Sie auf OK, um das MILLIPLEX® MAP-Tool zu schließen oder auf Abbrechen, um zu Ihrer Auswahl zurückzukehren.
Wählen Sie konfigurierbare Panels & Premixed-Kits - ODER - Kits für die zelluläre Signaltransduktion & MAPmates™
Konfigurieren Sie Ihre MILLIPLEX® MAP-Kits und lassen sich den Preis anzeigen.
Konfigurierbare Panels & Premixed-Kits
Unser breites Angebot enthält Multiplex-Panels, für die Sie die Analyten auswählen können, die am besten für Ihre Anwendung geeignet sind. Unter einem separaten Register können Sie das Premixed-Cytokin-Format oder ein Singleplex-Kit wählen.
Kits für die zelluläre Signaltransduktion & MAPmates™
Wählen Sie gebrauchsfertige Kits zur Erforschung gesamter Signalwege oder Prozesse. Oder konfigurieren Sie Ihre eigenen Kits mit Singleplex MAPmates™.
Die folgenden MAPmates™ sollten nicht zusammen analysiert werden: -MAPmates™, die einen unterschiedlichen Assaypuffer erfordern. -Phosphospezifische und MAPmate™ Gesamtkombinationen wie Gesamt-GSK3β und Gesamt-GSK3β (Ser 9). -PanTyr und locusspezifische MAPmates™, z.B. Phospho-EGF-Rezeptor und Phospho-STAT1 (Tyr701). -Mehr als 1 Phospho-MAPmate™ für ein einziges Target (Akt, STAT3). -GAPDH und β-Tubulin können nicht mit Kits oder MAPmates™, die panTyr enthalten, analysiert werden.
.
Bestellnummer
Bestellinformationen
St./Pkg.
Liste
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Wählen Sie bitte Spezies, Panelart, Kit oder Probenart
Um Ihr MILLIPLEX® MAP-Kit zu konfigurieren, wählen Sie zunächst eine Spezies, eine Panelart und/oder ein Kit.
Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Spezies
Panelart
Gewähltes Kit
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
96-Well Plate
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
Weitere Reagenzien hinzufügen (MAPmates erfordern die Verwendung eines Puffer- und Detektionskits)
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Platzsparende Option Kunden, die mehrere Kits kaufen, können ihre Multiplex-Assaykomponenten in Kunststoffbeuteln anstelle von Packungen erhalten, um eine kompaktere Lagerung zu ermöglichen.
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Das Produkt wurde in Ihre Bestellung aufgenommen
Sie können nun ein weiteres Kit konfigurieren, ein Premixed-Kit wählen, zur Kasse gehen oder das Bestell-Tool schließen.
Anti-Src, clone GD11, Cat. No. 05-184-I, is a mouse monoclonal antibody that detects Proto-oncogene tyrosine-protein kinase Src and is tested for use in Immunoprecipitation, and IP-Kinase Assay, and Western Blotting.
More>>Anti-Src, clone GD11, Cat. No. 05-184-I, is a mouse monoclonal antibody that detects Proto-oncogene tyrosine-protein kinase Src and is tested for use in Immunoprecipitation, and IP-Kinase Assay, and Western Blotting. Less<<
Empfohlene Produkte
Übersicht
Replacement Information
Description
Catalogue Number
05-184-I-100UL
Description
Anti-Src Antibody, clone GD11
Alternate Names
Proto-oncogene tyrosine-protein kinase Src
EC:2.7.10.2
Proto-oncogene c-Src
p60-Src
Background Information
Proto-oncogene tyrosine-protein kinase Src (UniProt: P12931; EC:2.7.10.2, Proto-oncogene c-Src, p60-Src) is encoded by the SRC (also known as SRC1) gene (Gene ID: 6714) in human. c-Src is expressed ubiquitously and platelets, neurons, and osteoclasts express several fold higher levels than most other tissues. c-Src, is found to be over-expressed and highly activated in a wide variety of human cancers and in several tumor cell lines. Src is a non-receptor protein tyrosine kinase that is activated following engagement of many different classes of cellular receptors. Src participates in signaling pathways that control a variety of biological processes including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. It is one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinases. Its protein kinase domain is localized in amino acids 270-523. Src has a SH3 domain (aa 84-135) and a SH2 domain (aa 151-248) that are important for the intramolecular and intermolecular interactions that regulate its catalytic activity, localization, and substrate recruitment. Src can undergo phosphorylation on tyrosine 530 by c-Src kinase, which inhibits its kinase activity. Src is reported to assume an inactive conformation when this phosphotyrosine is bound by the SH2 domain in an intramolecular fashion.
References
Product Information
Format
Purified
Presentation
Purified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Anti-Src, clone GD11, Cat. No. 05-184-I, is a mouse monoclonal antibody that detects Proto-oncogene tyrosine-protein kinase Src and is tested for use in Immunoprecipitation, and IP-Kinase Assay, and Western Blotting.
Key Applications
Immunoprecipitation
IP-Kinase Assay
Western Blotting
Application Notes
IP-Kinase Assay: A representative lot detected Src in IP-Kinase Assay applications (Abrahamsen, H., et. al. (2003). J Biol Chem. 278(19):17170-7; Shih, W.L., et. al. (2003). J Biol Chem. 278(34):31807-13)
Western Blotting Analysis: A representative lot detected Src in Western Blotting applications (Parsons, S.J., et. al. (1984). J Virol. 51(2):272-82; Abrahamsen, H., et. al. (2003). J Biol Chem. 278(19):17170-7; Kuo, F.T., et. al. (2006). Cell Signal. 18(11):1914-23).
Immunoprecipitation Analysis: A representative lot detected Src in Immunoprecipitation applications (Shih, W.L., et. al. (2003). J Biol Chem. 278(34):31807-13; Parsons, S.J., et. al. (1984). J Virol. 51(2):272-82).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Biological Information
Immunogen
A recombinant fragment expressed in E.coli corresponding to 88 amino acids from the N-terminal half of human Proto-oncogene tyrosine-protein kinase Src (c-Src).
Epitope
N-terminal half, SH3 domain
Clone
GD11
Concentration
0.5 mg/mL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Host
Mouse
Specificity
Clone GD11 is a mouse monoclonal antibody that detects Proto-oncogene tyrosine-protein kinase Src (c-Src). It targets an epitope within 88 amino acids from the N-terminal half.
~58 kDa observed; 59.84 kDa calculated. Uncharacterized bands may be observed in some lysate(s).
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality Assurance
Evaluated by Western Blotting in A431 cell lysates.
Western Blotting Analysis: A 1:500 dilution of this antibody detected Src in A431 cell lysates.
Usage Statement
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage Conditions
Stable for 1 year at +2°C to +8°C from date of receipt.
Opposing effects of beta-arrestin1 and beta-arrestin2 on activation and degradation of Src induced by protease-activated receptor 1. Kuo FT, Lu TL, Fu HW. Cell Signal
18(11)
1914-23
2005
Protease-activated receptor 1 (PAR1), a G protein-coupled receptor for thrombin, is irreversibly proteolytically activated. beta-Arrestin1 and beta-arrestin2 have been reported to have different effects on signal desensitization and transduction of PAR1. In this study, we investigated whether beta-arrestin1 and beta-arrestin2 regulate Src-dependent activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) induced by PAR1 in HEK 293 cells. Our results show that PAR1-mediated activation of Src and ERK1/2 in HEK 293 cells was increased with overexpression of beta-arrestin1 or depletion of beta-arrestin2. PAR1-mediated activation of Src and ERK1/2 in HEK 293 cells was decreased or eliminated with depletion of beta-arrestin1 or overexpression of beta-arrestin2. Furthermore, depletion of beta-arrestin2 blocked PAR1-induced degradation of Src. Thus, beta-arrestin1 and beta-arrestin2 have opposing roles in regulating the activation of Src induced by PAR1. beta-Arrestin2 also appears to promote PAR1-induced degradation of Src. This degradation of Src provides a possible mechanism for terminating PAR1 signaling.
Regulation of Src kinase activity is tightly coupled to the phosphorylation status of the C-terminal regulatory tyrosine Tyr(527), which, when phosphorylated by Csk, represses Src. Here, we demonstrate that activation of Csk through a prostaglandin E(2)-cAMP-protein kinase A (PKA) pathway inhibits Src. This inhibitory pathway is operative in detergent-resistant membrane fractions where cAMP-elevating agents activate Csk, resulting in a concomitant decrease in Src activity. The inhibitory effect on Src depends on a detergent-resistant membrane-anchored Csk and co-localization of all components of the inhibitory pathway in membrane microdomains. Furthermore, epidermal growth factor-induced activation of Src and phosphorylation of the Src substrates Cbl and focal adhesion kinase are inhibited by activation of the cAMP-PKA-Csk pathway. We propose a novel mechanism whereby G protein-coupled receptors inhibit Src signaling by activation of Csk in a cAMP-PKA-dependent manner.
Hepatitis B virus X protein activates a survival signaling by linking SRC to phosphatidylinositol 3-kinase. Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL. J Biol Chem
278(34)
31807-13
2003
We have previously shown that transactivation-proficient hepatitis virus B X protein (HBx) protects Hep 3B cells from transforming growth factor-beta (TGF-beta)-induced apoptosis via activation of the phosphatidylinositol 3-kinase (PI 3-kinase)/Akt signaling pathway. This work further investigated how HBx activates PI 3-kinase. Src activity was elevated in Hep 3B cells following expression of transactivation-proficient HBx or HBx-GFP fusion proteins. The Src family kinase inhibitor PP2 and C-terminal Src kinase (Csk) both alleviated HBx-mediated PI 3-kinase activation and protection from TGF-beta-induced apoptosis. Therefore, HBx activated a survival signal by linking Src to PI 3-kinase. Systemic subcellular fractionation and membrane flotation assays indicated that approximately 1.5% of ectopically expressed HBxGFP was associated with periplasmic membrane where Src was located. However, neither nucleus-targeted nor periplasmic membrane-targeted HBxGFP was able to upregulate Src activity or to augment PI 3-kinase survival signaling pathway.
Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin S J Parsons, D J McCarley, C M Ely, D C Benjamin, J T Parsons J Virol
51(2)
272-82
1983
The derivation and characterization of 22 hybridoma clones producing monoclonal antibodies (Mabs) specific for the transforming protein of Rous sarcoma virus, pp60src, are described. All Mabs reacted with pp60v-src encoded by Prague, Schmidt-Ruppin, and Bratislava 77 strains of Rous sarcoma virus. Of these Mabs, 10 efficiently immunoprecipitated pp60c-src from chicken embryo cells. Of these 10 Mabs, 2 (GD11 and EB8) readily detected pp60c-src from a variety of rodent and human cultured cells and from rat brain tissue in an in vitro immune complex kinase assay. Mapping experiments have tentatively localized the determinant(s) recognized by GD11 and EB8 to a region of the src protein bounded by amino acid residues 82 to 169, whereas the remaining Mabs appeared to recognize determinants residing within residues 1 to 82 or 169 to 173. Most of the Mabs complexed denatured pp60v-src in a Western immunoblot, and several were used to localize pp60v-src in Rous sarcoma virus-transformed chicken embryo cells by indirect immunofluorescence microscopy.